Live news related to GALAPAGOS stock (BE0003818359): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Galapagos NV has announced a binding framework agreement with Gilead Sciences concerning Gilead's acquisition of Ouro Medicines. This agreement struct…
Galapagos NV has released its 2025 annual report and announced a joint ordinary general meeting and extraordinary general meeting scheduled for April …
On March 23, 2026, Galapagos announced that it was in advanced discussions with Gilead Sciences to establish a strategic partnership involving OM336 (…
On March 5, 2026, Galapagos NV announced the appointment of Tania Philipp as Chief Human Resources Officer (CHRO), effective from March 4, 2026. Tania…
On Monday, biotechnology group Galapagos released its financial results for the year 2025, marked by a dramatic recovery in net income due to the rele…
Galapagos NV has announced the appointment of Dr. Paulo Fontoura as an independent non-executive director to its board, effective from February 9, 202…
The biotechnology group Galapagos announced on January 5th the decision of its board of directors to commence the closure of its cell therapy operatio…
Belgian laboratory Galapagos announced on December 18 the results of two phase 3 studies evaluating its selective TYK2 inhibitor, GLPG3667. The trial …
Galapagos NV has announced new Phase 2 data on its therapeutic candidate GLPG5101 during the annual meeting of the American Society of Hematology.
The stock of Belgian biotech company Galapagos ended the session on Tuesday, October 21, with a sharp decline of 5.87%, closing at 27.88 euros. This d…
